Amplified Sciences
Accurate. Earlier. Detection.
San Francisco, United States · Founded 2016 · $2.6M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- amplifiedsciences.com
- Total Funding
- $2.6M
- Last Round
- $2.6M SeedNov 2024
- Rounds
- 1
About
Amplified Sciences is a diagnostics company committed to providing innovative tests that enable earlier detection, risk stratification, and monitoring of challenging diseases. The company was spun out of Purdue University in 2016 and is built on a proprietary ultra-sensitive optical reporter platform leveraging novel dye chemistry and chemometric tools to form a highly versatile clinical assay platform. Its first commercial product, PanCystPro™, targets early detection of undiagnosed pancreatic cancers in high-risk patients and is available through its CLIA-CAP accredited laboratory. Amplified Sciences has received SBIR grants from NIH-NCI and NSF, and was selected for the 2025 MedTech Innovator BioTools cohort and the American Gastroenterology Association 'Improving GI Care' startup incubator.
Summary
Amplified Sciences is a Healthcare company based in San Francisco, United States, founded in 2016. It has raised $2.6M in total across 1 round, most recently a $2.6M Seed round in Nov 2024. Investors include Elevate Capital, OCA Ventures and IU Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company